[1] Zhu A, Bruketa E, Svoboda T, et al.Respiratory infectious disease outbreaks among people experiencing homelessness: A systematic review of prevention and mitigation strategies[J]. Ann Epidemiol, 2023, 77: 127-135.
[2] 高艳春, 沈凌, 王丽苹, 等. 2015—2021年中国大陆法定传染病流行趋势分析[J]. 云南医药, 2023, 44(4): 9-13.
[3] 蔡靖靖, 栾荣生. 2017—2022年四川省法定传染病流行特征分析[J]. 现代预防医学, 2023, 50(9): 1566-1571.
[4] 陈耿娜, 李伟南, 姚丽君, 等. 2011—2020年汕头市登革热流行特征及时空聚集性分析[J]. 华南预防医学, 2024, 50(8): 716-719, 723.
[5] Chow EJ, Uyeki TM, Chu HY.The effects of the COVID-19 pandemic on community respiratory virus activity[J]. Nat Rev Microbiol, 2023, 21(3): 195-210.
[6] 戴灵, 刘印, 康孟利, 等. 新冠疫情对儿科门急诊的影响及对策研究[J]. 医院管理论坛, 2022, 39(2): 22-25.
[7] 李锃亮. 杭州市主城区新型冠状病毒肺炎疫情防控期间上呼吸道急性疾病发病的时间序列研究[D]. 杭州: 浙江中医药大学, 2022.
[8] Feinmann J.Analysis reveals global post-covid surge in infectious diseases[J]. BMJ, 2024, 385: q1348.
[9] He Y, Liu WJ, Jia N, et al.Viral respiratory infections in a rapidly changing climate: The need to prepare for the next pandemic[J]. EBioMedicine, 2023, 93: 104593.
[10] World Health Organization. Review of global influenza circulation, late2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation[EB/OL]. (2021-06-25)[2025-06-16]. https: //www.who.int/publications/i/item/who-wer-9625-241-264.
[11] Cowling BJ, Ali ST, Ng TWY, et al.Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: An observational study[J]. Lancet Public Health, 2020, 5(5): e279-e288.
[12] Chen L, Guo Y, López-Güell K, et al.Immunity debt for seasonal influenza after the COVID-19 pandemic and as a result of nonpharmaceutical interventions: An ecological analysis and cohort study[J]. Adv Sci (Weinh), 2025, 12(20): e2410513.
[13] 李静, 赵艺明, 王猛, 等. 2017—2023年上海市金山区流感样病例监测结果分析[J]. 华南预防医学, 2025, 51(8): 903-907.
[14] 赵宏婷, 彭质斌, 倪兆林, 等. 2020—2021和2021—2022年度流感流行季我国流感疫苗接种政策和接种情况调查[J]. 中华预防医学杂志, 2022, 56(11): 1560-1564.
[15] 王晓琪, 周泽玫, 许侠, 等. 2005—2023年中国流行性腮腺炎发病趋势的Joinpoint回归模型和年龄-时期-队列模型分析[J]. 中国疫苗和免疫, 2024, 30(6): 642-646.
[16] Zhang W, Luan R.Estimating the impact of non-pharmaceutical interventions against COVID-19 on mumps incidence in Sichuan, China[J]. BMC Infect Dis, 2021, 21(1): 886.
[17] Lam E, Rosen JB, Zucker JR.Mumps: An update on outbreaks, vaccine efficacy, and genomic diversity[J]. Clin Microbiol Rev, 2020, 33(2): e00151-19.
[18] 刘亿, 刘宇, 李银乔, 等. 2022年四川省0~6岁儿童麻疹、风疹和流行性腮腺炎抗体水平监测[J]. 中国疫苗和免疫, 2023, 29(5): 508-511.
[19] 杨圣元, 唐利红, 周毅彬, 等. 2017—2022年上海市闵行区肺结核流行特征分析[J]. 华南预防医学, 2024, 50(12): 1191-1194, 1198.
[20] 夏岚, 陈闯, 张佩如, 等. 2011—2020年四川省结核病防治工作成就与展望[J]. 预防医学情报杂志, 2025, 41(3): 285-292.
[21] 国家统计局. 《中国儿童发展纲要(2011—2020年)》终期统计监测报告[EB/OL]. (2021-12-21)[2025-02-07]. https://www.gov.cn/xinwen/2021-12/21/content_5663694.htm.
[22] Martinez L, Cords O, Liu Q, et al.Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: A systematic review and individual participant data meta-analysis[J]. Lancet Glob Health, 2022, 10(9): e1307-e1316.
[23] Gao W, Wang W, Li J, et al.Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China[J]. Antimicrob Resist Infect Control, 2024, 13(1): 125.
[24] Bagcchi S.WHO's global tuberculosis report 2022[J]. Lancet Microbe, 2023, 4(1): e20.
[25] Yu J, He H, Zhang Y, et al.Burden of whooping cough in China (PertussisChina): Study protocol of a prospective, population-based case-control study[J]. BMJ Open, 2022, 12(3): e053316.
[26] 张恺, 漆琪, 刘家洁, 等. 2014—2022年四川省百日咳流行病学特征[J]. 中国疫苗和免疫, 2023, 29(4): 407-411.
[27] Mengyang G, Yahong H, Qinghong M, et al.Resurgence and atypical patterns of pertussis in China[J]. J Infect, 2024, 88(4): 106140.
[28] 国家疾病预防控制局. 关于国家免疫规划百白破疫苗和白破疫苗免疫程序调整相关工作的通知[EB/OL]. (2024-12-25)[2025-02-07]. https://www.ndcpa.gov.cn/jbkzzx/c100014/common/content/content_1872098276166717440.html. |
